Drug Trial Radar · NCT06973291
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
Last checked: Nov 20, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
606
Actual
Start
Jul 9, 2025
Primary completion
Apr 22, 2026
Study completion Apr 22, 2026
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- May 15, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main aim of this study is to assess whether zasocitinib works better than deucravacitinib in treating participants with moderate-to-severe plaque psoriasis. Participants will take one tablet daily of either zasocitinib or a matching placebo, along with one capsule daily of either over-encapsulated deucravacitinib or a matching placebo, for a duration of 16 weeks. Participants will be in the study for up to 25 weeks, which includes screening period of up to 35 days, a 16-week treatment period, and a 4-week safety follow-up period.
Conditions
- Plaque Psoriasis
Interventions
ZasocitinibDrug
Zasocitinib tablets.
DeucravacitinibDrug
Deucravacitinib capsules.
Placebo to match zasocitinibDrug
Zasocitinib matching placebo tablets.
Placebo to match deucravacitinibDrug
Deucravacitinib matching placebo capsules.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving Psoriasis Area and Severity Index (PASI)-100 at Week 16Time frame: At Week 16
Locations
113 sites in 8 countries. Site status is shown where the registry gives one.
Johnson Dermatology
Fort Smith, Arkansas
Burke Pharmaceutical Research
Hot Springs, Arkansas
Zenith Research, Inc.
Beverly Hills, California
First OC Dermatology Research Inc.
Fountain Valley, California
UNISON Clinical Trials (Shahram Jacobs md inc.)
Sherman Oaks, California
Central Connecticut Dermatology, PLLC
Cromwell, Connecticut
Yale University School of Medicine
New Haven, Connecticut
Direct Helpers Research Center
Hialeah, Florida
San Marcus Research Clinic Inc
Miami Lakes, Florida
Advanced Clinical Research Institute
Tampa, Florida
Arlington Dermatology
Rolling Meadows, Illinois
Endeavor Health Clinical Trials
Skokie, Illinois
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana
Lawrence J Green, MD LLC
Rockville, Maryland
Henry Ford Health System
Detroit, Michigan
JDR Dermatology Research, LLC
Las Vegas, Nevada
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire
Markowitz Medical PLLC dba OptiSkin Medical
New York, New York
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Bexley Dermatology Research - Probity - PPDS
Bexley, Ohio
Apex Clinical Research Center, LLC - Canton
Canton, Ohio
Apex Clinical Research Center, LLC - Mayfield Heights
Mayfield Heights, Ohio
UPMC Department of Dermatology
Pittsburgh, Pennsylvania
Goodlettsville Dermatology Research
Goodlettsville, Tennessee
Arlington Research Center
Arlington, Texas
Bellaire Dermatology Associates
Bellaire, Texas
The University of Texas Health Science Center at Houston (UTHSC-H)
Bellaire, Texas
Reveal Research Institute
Dallas, Texas
San Antonio
San Antonio, Texas
Texas Dermatology and Laser Specialists-San Antonio
San Antonio, Texas
Houston Center for Clinical Research, LLC
Sugar Land, Texas
Multiprofile Hospital For Active Treatment Dr Tota Venkova
Gabrovo, Bulgaria
Diagnostic Consultative Center Sveti Georgi EOOD
Haskovo, Bulgaria
Medical Center Medconsult Pleven - Lovech Branch
Lovech, Bulgaria
Medical Centre Femiclinic EOOD
Sofia, Dianabad District, Bulgaria
Medical Center Unimed EOOD-Sevlievo
Sevlievo, Gabrovo, Bulgaria
Medical Center Asklepii OOD
Dupnitsa, Kyustendil, Bulgaria
Diagnostic and Consulting Center Aleksandrovska EOOD
Sofia, Sofia-Grad, Bulgaria
Medical Center Hera EOOD-Sofia
Sofia, Sofia-Grad, Bulgaria
Diagnostic Consultative Center XXVIII - Sofia - EOOD
Sofia, Sofia-Grad, Bulgaria
Showing 40 of 113 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.